This document discusses strategies to reduce blood transfusions for patients undergoing hip and knee arthroplasty. It provides evidence that restrictive transfusion protocols with a threshold of 8 g/dL are safe based on multiple studies. Transfusions are associated with increased risks of infection, mortality and costs. The document reviews transfusion rates among MARCQI sites and recommends adoption of restrictive guidelines and use of tranexamic acid to reduce transfusions when possible.